More Steps Forward – Highlights of Praxis SCI Incubate and Accelerate Alumni Companies
Praxis SCI Incubate and SCI Accelerate alumni companies have made significant strides in recent months. These include clinical trials, awards, funding, and global recognition. Accomplishments highlight the success of the Commercialization program that supports entrepreneurs in the spinal cord injury community.
Scroll to see a list of accomplishments from our alumni companies.
Program Updates
| Program Name | Accomplishment | Type | News Link |
| SCI Accelerate 2020 | Developing breakthrough non-invasive devices for neurological disorders, spasticity and Amyotrophic Lateral Sclerosis (ALS), PathMaker Neurosystems Inc., announced an investment of $600,000 through the MDA Venture Philanthropy (MVP) program to advance its research into ALS. | Funding | https://pmneuro.com/muscular-dystrophy-association-awards-venture-philanthropy-funding-to-pathmaker-neurosystems-to-develop-neuromodulation-treatment-for-als/ |
| SCI Accelerate 2022 | Comphya, a Swiss company developing the first implantable neurostimulator aimed at treating erectile dysfunction (ED), has raised funds for its pilot clinical trials. Praxis Spinal Cord Institute is pleased to support Comphya’s research as an additional investor to improve the quality of life of individuals living with a spinal cord injury. | Funding | https://comphya.com/news/successfully-additional-clinical/ |
| SCI Accelerate 2022 | A pilot study has also been initiated by Comphya in Australia. Clinical trials involving CaverSTIM in patients undergoing prostatectomy have been approved by the Australian regulatory authorities (Human Research Ethics Committees (HREC) and Therapeutic Goods Administration (TGA). | Clinical Trials | https://comphya.com/news/receives-approval-australia/ |
| SCI Incubate 2020-21 | Spiderwort wins prestigious Judge’s Choice Award at Octane Medical Aesthetics Tech Forum. Biomaterials developed by Spiderwort have shown promise in treating spinal cord injuries and regenerating soft tissue. | Award | https://spiderwortbio.com/news/spiderwort-wins-judges-choice-award-at-octane-medical-aesthetics-forum/ |
| SCI Incubate 2020-21 | SynGAP Research Fund (SRF) announced a $130,000 collaborative grant including AXONIS Therapeutics to investigate the treatment effects of KCC2-enhancing small molecule compounds on SYNGAP1 haploinsufficiency. The funding will support people who are currently living with this ultra-rare disease, without treatment or cure. | Funding/Partnership | https://www.eurekalert.org/news-releases/985108 |
| SCI Incubate 2021-22 | Kalogon listed as a top start-up to watch by Space Coast Daily. Kalogon is an innovative technology that focuses on smart cushions designed specifically for wheelchair users. The team also received global recognition as the Most Innovative Product in Accessibility at this year’s Consumer Electronics Show. | Recognition | https://spacecoastdaily.com/2023/01/groundswell-startups-kalogon-swiftpaws-and-spaced-ventures-named-top-startups-to-watch/ |
| SCI Incubate 2021-22 | NanoTess, a Calgary-based nanotech company developing technologies to address chronic wounds, announces its partnership with the Coordinated Accessible National (CAN) Health Network. The partnership will provide NanoTess access to a network of real-world environments to apply its solution, mentorship from coaches and subject matter experts, and assistance in navigating the healthcare marketplace to collaborate toward scaling and procurement. | Partnership | https://canhealthnetwork.ca/revolutionary-nanotechnology-company-joins-can-health-network/ |
| Inaugural SCI Validate 2022 | Through Persons with Lived Experience (PLEX) and clinical team involvement, Praxis supports Harrisburg University’s e-sports team in testing out the new revolutionary earbud technology – NAQI Logix. Donate to NAQI’s crowd funding campaign here https://www.investnaqi.com/ | Support | https://www.fox43.com/article/tech/harrisburg-university-e-sports-team-naqi-earbud-technology-video-games/521-01390a0d-e589-4f63-a6a8-d2a9b0b21553 |
Learn more about Praxis Commercialization programs here.